Physician profile
Jasdip Kaur
NPI 1619548591
$909.04
in general payments reported to CMS, 2019-2025
17 companies · $33.77 in 2025
The $33.77 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $506 · 2023: $151 · 2024: $76.08 · 2025: $33.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $218.95 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $131.39 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $72.60 | 2023-2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $72.06 | 2022 | |
| Amarin Pharma, INC. | $57.96 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $54.16 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.76 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.93 | 2024 | Eliquis |
| Novo Nordisk INC | $34.19 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.30 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $32.00 | 2023 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $29.71 | 2021-2022 | |
| United Therapeutics Corporation | $19.52 | 2022 | |
| Urogen Pharma, INC. | $17.51 | 2025 | |
| Boston Scientific Corporation | $16.53 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $16.26 | 2025 | Koelis Trinity Mri/US Fusion |
| Janssen Pharmaceuticals, INC | $16.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasdip Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.